Adi Zuloff-Shani
CTO @ SciSparc
Adi Zuloff-Shani is a startup investor at SciSparc. Adi Zuloff-Shani is the current CEO of Clearmind Medicine. She previously worked at Macrocure as a Vice President of Development. Adi Zuloff-Shani attended Bar-Ilan University.
Last updated:
For AI agents: llms.txt
About SciSparc
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
SciSparc Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ari Aminetzah
CEO
|
|||
|
Adi Zuloff-Shani
CTO
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
